4th Quarter - Report

VIROPHARMA INCORPORATED for VIROPHARMA INCORPORATED

Period 4th Quarter 2012 Filed Jan 22, 2013 Signed by John Greissing, Senior Director, Government Affairs and Health Policy

Official filing
Firm
VIROPHARMA INCORPORATED
Client
VIROPHARMA INCORPORATED
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Antibiotic incentives, essential health benefits, Federal grants for drug development, annual branded pharmaceutical fee, and Orphan Drug Act.

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.